National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

bcl-2 antisense oligodeoxynucleotide G3139 (... AN-tee-sents AH-lih-goh-dee-OK-see-NOO-klee-oh-TIDE ...)

 A substance being studied in the treatment of cancer. It may kill cancer cells by blocking the production of a protein that makes cancer cells live longer and by making them more sensitive to anticancer drugs. It is a type of antisense oligodeoxyribonucleotide. Also called augmerosen, Genasense, and oblimersen.



Previous Definitions:BBIC, BBR 2778, BBR 3464, BCG, BCG solution
Next Definitions:BCL2, BCR-ABL fusion gene, BCR-ABL fusion protein, BCX-1777, BDC

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov